Glioblastoma Multiforme (GBM) represents the most aggressive and lethal primary malignant brain tumor in adults, characterized by diffuse parenchymal infiltration, hypervascularity, profound resistance to standard Temozolomide (TMZ) chemotherapy, and extensive molecular heterogeneity. Bioactive organosulfur compounds derived from garlic (Allium sativum), particularly Diallyl Trisulfide (DATS), diallyl disulfide (DADS), and allicin, possess potent antineoplastic properties but are severely limited clinically by rapid volatilization, instability, low aqueous solubility, and insufficient Blood–Brain Barrier (BBB) penetration. In this investigation, cold-pressed Allium sativum lipophilic extracts were encapsulated into self-assembling poly (ethylene glycol)-block-poly (lactic-co-glycolic acid) (PEG-b-PLGA) polymeric nanomicelles (AS-NMs) to enhance intracellular stability and targeted bio-efficacy. Physicochemical characterization revealed monodisperse spherical vesicles (mean hydrodynamic diameter: 82.4 ± 3.8 nm; polydispersity index: 0.114; zeta potential: -18.7 ± 1.5 mV; encapsulation efficiency: 87.3%). Treatment of human glioblastoma models (U87MG, U251, and patient-derived primary glioma stem-like cells GSC-387) demonstrated dose-dependent cytotoxic synergy when AS-NMs were combined with low-dose TMZ, yielding Combination Index (CI) values between 0.38 and 0.54. Mechanistic pathway interrogation verified that AS-NMs trigger intrinsic mitochondrial apoptosis via selective elevation of intracellular reactive oxygen species (ROS), collapse of the mitochondrial membrane potential (ΔΨm), transcriptional and translational upregulation of pro-apoptotic Bax, downregulation of anti-apoptotic Bcl-2 and Mcl-1, cytochrome c release, and sequential cleavage of Caspase-9, Caspase-3, and Poly(ADP-ribose) polymerase (PARP). Concurrent attenuation of the oncogenic PI3K/Akt/mTOR axis, coupled with marked cell cycle arrest at the G2/M checkpoint, indicates that biomimetically engineered phytotherapeutic nanocarriers represent an efficacious adjuvant paradigm against treatment-refractory malignant gliomas.
Keywords:
Published on: Nov 11, 2026 Pages: 19-25
Full Text PDF
Full Text HTML
DOI: 10.17352/2455-3484.000062
CrossMark
Publons
Harvard Library HOLLIS
Search IT
Semantic Scholar
Get Citation
Base Search
Scilit
OAI-PMH
ResearchGate
Academic Microsoft
GrowKudos
Universite de Paris
UW Libraries
SJSU King Library
SJSU King Library
NUS Library
McGill
DET KGL BIBLiOTEK
JCU Discovery
Universidad De Lima
WorldCat
VU on WorldCat